Researchers report that people with higher levels of inflammation showed a stronger tendency to use social media rather than meet others in person. The team measured a blood marker called C-reactive protein (CRP) and also gathered phone screen time data.
The study included 154 participants who answered questions about personality and social media. The connection between online use and inflammation was more visible for people with introverted or neurotic traits. The researchers say social media can be easier than face-to-face talk, but it may harm some people’s well-being.
Next, the team plans to test other social technologies, including some AI companion apps.
Difficult words
- inflammation — body reaction that causes redness or swelling
- C-reactive protein — a blood marker that shows inflammation
- screen time — time spent looking at a phone or screen
- introverted — person who prefers small groups or alone
- neurotic — person who often feels anxious or worried
- well-being — a person's general health and happiness
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Do you use social media more than meet people in person? Why or why not?
- Do you think social media can help or harm a person's well-being? Give one reason.
- Would you prefer talking in person or online? Explain in one sentence.
Related articles
Touchscreens on car dashboards increase driver distraction
A simulator study found that using a car touchscreen while driving makes steering and touchscreen tasks worse. Multitasking reduced lane control and touchscreen accuracy; researchers suggest simple sensors could monitor attention and change the interface.
Blocking a key immune signal may prolong post-surgery pain
A study led by Geoffroy Laumet found that blocking the immune molecule TNF-α after surgery in mice made pain last longer. The authors warn this does not mean stopping all anti-inflammatory treatment and call for targeted approaches.
Simpler treatment trial for cryptococcal meningitis in Malawi
Cryptococcal meningitis kills many people in Sub‑Saharan Africa and mainly affects people with HIV. A Phase II trial in Lilongwe is testing a sustained‑release flucytosine pellet to make treatment easier, while clinicians warn that early testing and care remain vital.
